Latest data from the Hong Kong Stock Exchange reveals that on May 28, Norges Bank increased its holdings in TIGERMED (03347) by 825,700 shares. The transaction was executed at a price of HK$30.6386 per share, amounting to a total consideration of approximately HK$25.2983 million. Following this acquisition, Norges Bank's total shareholding in TIGERMED has risen to about 9.2157 million shares, representing a 7.48% stake in the company.